MedX Holdings Inc (MEDH) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of MedX Holdings Inc $0.00, price $0.00, upside +8.5%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch MedX Holdings Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
Stock analysis
MedX Holdings Inc (MEDH) currently trades at $0.0013, while our model-based Fair Value estimate is $0.0014, so the stock looks roughly fairly valued today (gap 7.8%).
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of $0.0100 per share, and 13 of the 13 models we run sit above the $0.0013 price.
Bear case: the DCF Models group reads lowest at $0.0100, and 0 of the 13 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
MedX Holdings Inc reported revenue of $1.8M in FY2025 versus $2.2M in FY2018, a compound −3.0%/yr. Reported net income was $269K in FY2025.
Key figures
Market cap $1.2M · P/S ratio 1.16 · EPS (TTM) $−0.0400 · Net margin 15.3% · Return on assets (EBIT) 1.1% · Operating margin 65.5% · Revenue (TTM) $1.1M · Revenue growth (YoY) −70.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 54% below its 52-week high and 160% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 25% fair-value upside, at 8%, MEDH screens richer than that median.
Fair Value models
Bear $0.0014Fair Value $0.0014Bull $0.0014
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.57/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+97.1%
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.4%
’07
’08
’17
’18
’19
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
42.1% (2018) → 10.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+37.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +33.8% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Tobacco · 34 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Bottom 25%
Fair Value upside+8.5% · Below median
Profitability
Return on assets0.0% · Bottom 25%
Net margin (TTM)1.6% · Bottom 25%
Operating margin (TTM)65.5% · Top 25%
Growth and dividend
Revenue growth−70.2% · Bottom 25%
Valuation Multiplesvs Tobacco median · lower = cheaper
P/B0.22× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is MedX Holdings Inc (MEDH) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0014 versus the last price from Sep 25, 2026 of $0.0013, about +8% upside (fairly valued).
What is the fair value of MEDH?
Our model-based fair value for MedX Holdings Inc is $0.0014 (as of Sep 27, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0013.
What is the quality score of MEDH?
MedX Holdings Inc has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MedX Holdings Inc (MEDH)?
Our model-based price target is the fair value of $0.0014 (as of Sep 27, 2026) from 18 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the MedX Holdings Inc stock forecast for 2026?
Our models put fair value at $0.0014, about +8% upside versus the last price from Sep 25, 2026 of $0.0013 (fairly valued). The calculation is refreshed regularly with new filings.
What is the revenue of MedX Holdings Inc (MEDH)?
MedX Holdings Inc reported trailing-twelve-month revenue of about $1.1M (latest available figure, as of Sep 27, 2026).
What growth is priced into MedX Holdings Inc (MEDH)?
For today's price to be fair in a discounted-cash-flow model, MedX Holdings Inc would have to grow free cash flow by +37.0 % per year for five years (discount rate 12.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 6 years revenue grew +2.9 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of MEDH use?
Our models discount MedX Holdings Inc at 12.2 %: a base by market capitalisation (nano), damped by beta 2.38, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For MedX Holdings Inc that is +37.0 % per year a year over ten years, using the same discount rate (12.2 %) and the same formula as our fair value.
How much growth has MedX Holdings Inc (MEDH) delivered so far?
Over the past 6 years revenue at MedX Holdings Inc grew +2.9 % a year. The price currently implies +37.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of MedX Holdings Inc (MEDH) growing?
The median revenue growth in the sector is +3.1 % a year. That is the yardstick for the growth priced into MedX Holdings Inc (+37.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of MedX Holdings Inc (MEDH)?
The free-cash-flow yield on the price is 1.69 %: that much free cash flow MedX Holdings Inc produces per unit of market value. When it exceeds the discount rate of our models (12.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of MedX Holdings Inc (MEDH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MedX Holdings Inc it is $0.0014 per share (as of Sep 27, 2026), against a price of $0.0013. It is the blended result of 18 valuation models (cash flow, earnings, asset, dividend).
Is MedX Holdings Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, MEDH trades below its calculated fair value: price $0.0013, fair value $0.0014, a gap of about +8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MEDH?
No. The price is what the market pays today ($0.0013); the fair value is what the company's own numbers justify ($0.0014). For MedX Holdings Inc the two are $0.0001 per share apart. That gap is exactly why we show both numbers side by side.
How much is MedX Holdings Inc worth?
The market values MedX Holdings Inc at about $1.2M (market capitalisation, as of Sep 27, 2026). Per share that is $0.0013; our models calculate a fair value of $0.0014 per share.
How far is MEDH from its 52-week high?
MedX Holdings Inc trades at $0.0013, about 54% below its 52-week high of $0.0028 and 160% above the low of $0.0005 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0014 is for.
Which stocks are comparable to MedX Holdings Inc?
From the same area (Consumer Defensive) we also value Philip Morris International Inc, British American Tobacco p.l.c., Altria Group, ITC Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MedX Holdings Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0013, calculated fair value $0.0014 (+8%), Quality Score 47/100, from 18 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MEDH calculated?
We run MedX Holdings Inc through 18 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0014, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. MedX Holdings Inc currently trades 8 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MedX Holdings Inc (MEDH)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0013. Our model-based fair value is $0.0014, about +8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MedX Holdings Inc right now?
The price is below even our cautious bear case ($0.0014). The market is more pessimistic than our downside scenario. The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of MedX Holdings Inc
How large is the market capitalisation of MedX Holdings Inc (MEDH)?
The market capitalisation of MedX Holdings Inc is $1.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MedX Holdings Inc (MEDH)?
The price-to-sales ratio of MedX Holdings Inc is 1.16 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MedX Holdings Inc (MEDH)?
Earnings per share at MedX Holdings Inc are $−0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of MedX Holdings Inc (MEDH)?
The net margin of MedX Holdings Inc is 15.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of MedX Holdings Inc (MEDH)?
On an EBIT basis the return on assets of MedX Holdings Inc is 1.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MedX Holdings Inc (MEDH)?
The operating margin of MedX Holdings Inc is 65.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MedX Holdings Inc (MEDH)?
Revenue at MedX Holdings Inc is growing −70.2% versus a year earlier (3y avg +5.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MedX Holdings Inc (MEDH)?
Earnings per share at MedX Holdings Inc are growing −75.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does MedX Holdings Inc (MEDH) carry?
The net debt of MedX Holdings Inc is $4.8M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch MedX Holdings Inc in the live analysis
One click puts MedX Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026